Medicinal Chemistry Research

, Volume 26, Issue 10, pp 2225–2234 | Cite as

Synthesis and molecular docking studies of chrysin derivatives as antibacterial agents

Review Article
  • 135 Downloads

Abstract

In order to search for drugs with excellent antibacterial activities, a series of novel chrysin derivatives were designed, synthesized, and evaluated as antibacterial agents. Results of the preliminary antibacterial tests against six human pathogenic bacteria in vitro showed that these compounds exhibited activities to some extent, and some displayed excellent activities than the natural parent chrysin, while some were even more potent than the positive drug Penicillin. Moreover, the molecular model for the binding between compound 8c and the active site of Escherichia coli β-ketoacyl-acyl carrier protein synthase III (Escherichia coli FabH) was provided on the basis of the computational docking results.

Keywords

Chrysin Design Synthesis Molecular docking 

Notes

Acknowledgements

This work was supported by the National Natural Science Foundation of China (Nos. 81473104). We thank Jun Zhang for the help of molecular docking.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no competing interests.

References

  1. Alvarez R, Velázquez S, San-Félix A, Aquaro S, De CE, Perno CF, Karlsson A, Balzarini J, Camarasa MJ (1994) 1,2,3-Triazole-[2’,5’-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl] -3’-spiro-5”-(4”- amino -1”,2”-oxathiole 2”,2”-dioxide) (TSAO) analogues: synthesis and anti-HIV-1 activity. J Med Chem 37:4185–4194CrossRefPubMedGoogle Scholar
  2. Anitha TA, Rajadurai M (2014) Antioxidative potential of chrysin, a flavone in streptozotocin–nicotinamide-induced diabetic rats. Biomed Prev Nutr 4:511–517CrossRefGoogle Scholar
  3. Aridoss G, Amirthaganesan S, Kumar NA, Kim JT, Lim KT, Kabilan S, Jeong YT (2008) A facile synthesis, antibacterial, and antitubercular studies of some piperidin-4-one and tetrahydropyridine derivatives. Bioorg Med Chem Lett 18:6542–6548CrossRefPubMedGoogle Scholar
  4. Buckle DR, Rockell CJ, Smith H, Spicer BA (1984) Studies on 1,2,3-triazoles. 10. Synthesis and antiallergic properties of 9-oxo-1H,9H-benzothiopyrano[2,3-d]-1,2,3-triazoles and their S-oxides. J Med Chem 27:223–227CrossRefPubMedGoogle Scholar
  5. Chai XY, Yang G, Zhang J, Yu SC, Zou Y, Wu QY, Zhang DZ, Jiang YY, Cao YB, Sun QY (2012) Synthesis and biological evaluation of triazole derivatives as potential antifungal agent. Chem Biol Drug Des 80:382–387CrossRefPubMedGoogle Scholar
  6. Christensen CE, Kragelund BB, von Wettstein-Knowles P, Henriksen A (2007) Structure of the human beta-ketoacyl [ACP] synthase from the mitochondrial type II fatty acid synthase. Protein Sci 16:261–272CrossRefPubMedPubMedCentralGoogle Scholar
  7. CLSI (2012) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard-ninth edition. CLSI Document M07-A9. CLSI, WayneGoogle Scholar
  8. Dalvie DK, Kalgutkar AS, Khojasteh-Bakht SC, Obach RS, O’Donnell JP (2002) Biotransformation reactions of five-membered aromatic heterocyclic rings. Chem Res Toxicol 15:269–299CrossRefPubMedGoogle Scholar
  9. Genin MJ, Allwine DA, Anderson DJ, Barbachyn MR, Emmert DE, Garmon SA, Graber DR, Grega KC, Hester JB, Hutchinson DK, Morris J, Reischer RJ, Ford CW, Zurenko GE, Hamel JC, Schaadt RD, Stapert D, Yagi BH (2000) Substituent effects on the antibacterial activity of nitrogen-carbon-linked (azolylphenyl)oxazolidinones with expanded activity against the fastidious gram-negative organisms Haemophilus influenzae and Moraxella catarrhalis. J Med Chem 43:953–970CrossRefPubMedGoogle Scholar
  10. Heinemann JA, Ankenbauer RG, Amábile-Cuevas CF (2000) Do antibiotics maintain antibiotic resistance? Drug Discov Today 5:195–204CrossRefPubMedGoogle Scholar
  11. Hirokawa Y, Kinoshita H, Tanaka T, Nakamura T, Fujimoto K, Kashimoto S, Kojima T, Kato S (2008) Pleuromutilin derivatives having a purine ring. Part 1: new compounds with promising antibacterial activity against resistant Gram-positive pathogens. Bioorg Med Chem Lett 18:3556–3561CrossRefPubMedGoogle Scholar
  12. Horne WS, Yadav MK, Stout CD, Ghadiri MR (2004) Heterocyclic peptide backbone modifications in an alpha-helical coiled coil. J Am Chem Soc 126:15366–15367CrossRefPubMedPubMedCentralGoogle Scholar
  13. Kasala ER, Bodduluru LN, Barua CC, Gogoi R (2015) Chrysin and its emerging role in cancer drug resistance. Chem Biol Interact 236:7–8CrossRefPubMedGoogle Scholar
  14. Komine T, Kojima A, Asahina Y, Saito T, Takano H, Shibue T, Fukuda Y (2008) Synthesis and structure-activity relationship studies of highly potent novel oxazolidinone antibacterials. J Med Chem 51:6558–6562CrossRefPubMedGoogle Scholar
  15. Leeb M (2004) Antibiotics: a shot in the arm. Nature 431:892–893CrossRefPubMedGoogle Scholar
  16. Li HQ, Shi L, Li QS, Liu PG, Luo Y, Zhao J, Zhu HL (2009) Synthesis of C(7) modified chrysin derivatives designing to inhibit β-ketoacyl-acyl carrier protein synthase III (FabH) as antibiotics. Bioorg Med Chem 17:6264–6249CrossRefPubMedGoogle Scholar
  17. Minassi A, Giana A, Ech-Chahad A, Appendino G (2008) A regiodivergent synthesis of ring a C-prenylflavones. Org Lett 10:2267–2270CrossRefPubMedGoogle Scholar
  18. Newman DJ, Cragg GM, Snader KM (2003) Natural products as sources of new drugs over the period 1981-2002. J Nat Prod 66:1022–1037CrossRefPubMedGoogle Scholar
  19. Newman DJ (2008) Natural products as leads to potential drugs: an old process or the new hope for drug discovery? J Med Chem 51:2589–2599CrossRefPubMedGoogle Scholar
  20. Payne DJ, Gwynn MN, Holmes DJ, Pompliano DL (2007) Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat Rev Drug Discov 6:29–40CrossRefPubMedGoogle Scholar
  21. Qiu X, Janson C, Smith W, Head M, Lonsdale J, Konstantinidis A (2001) Refined structures of β-ketoacyl-acyl carrier protein synthase III. J Mol Biol 307:341–356CrossRefPubMedGoogle Scholar
  22. Rauf A, Khan R, Raza M, Khan H, Pervez S, De FV, Maione F, Mascolo N (2015) Suppression of inflammatory response by chrysin, a flavone isolated from Potentilla evestita Th. Wolf. In silico predictive study on its mechanistic effect. Fitoterapia 103:129–135CrossRefPubMedGoogle Scholar
  23. Sánchez I, Gómez-Garibay F, Taboada J, Ruiz BH (2000) Antiviral effect of flavonoids on the dengue virus. Phytother Res 14:89–92CrossRefPubMedGoogle Scholar
  24. Shahjahan KM, Engelbrecht K, Polanowski R, Krueger SM, Ignasiak R, Rott M, Schwan WR, Stemper ME, Reed KD, Sherman D, Cook JM, Monte A (2008) New classes of Gram-positive selective antibacterials: inhibitors of MRSA and surrogates of the causative agents of anthrax and tuberculosis. Bioorg Med Chem Lett 18:5745–5749CrossRefGoogle Scholar
  25. Suresh BK, Hari BT, Srinivas PV, Hara KK, Murthy US, Rao JM (2006) Synthesis and biological evaluation of novel C (7) modified chrysin analogues as antibacterial agents. Bioorg Med Chem Lett 16:221–224CrossRefGoogle Scholar
  26. Xu L, Farthing AK, Dropinski JF, Meinke PT, McCallum C, Leavitt PS, Hickey EJ, Colwell L, Barrett J, Liu K (2009) Nocathiacin analogs: Synthesis and antibacterial activity of novel water-soluble amides. Bioorg Med Chem Lett 19:3531–3535CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2017

Authors and Affiliations

  1. 1.School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation; Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of ShandongYantai UniversityYantaiChina

Personalised recommendations